samedan logo
 
 
 
spacer
home > pmps > summer 2007 > agility ability
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Agility Ability

Carl Dugdale at George Group Consulting assesses the competitive advantage of achieving ‘agility’ across the industry

Today, many pharmaceutical organisations are still looking towards mergers to drive increased shareholder value, even though study after study continues to show that long term value is rarely achieved through acquisition – at least not to the acquirer. In our opinion, the most successful long term approach to delivering real value is through organic revenue growth from innovative new products and services. It should be noted that the most successful companies derive 25 per cent or more of their revenue from products or services, which are less than three years old.

To be truly successful, new offers must be differentiated. This can be in terms of product functionality, service offer, target market or any combination of these factors. A great example is Apple’s iPod/iTunes. This combined a radically new physical product with a radically new service design and process, as well as a new market definition. The effect: the redefinition of an entire industry. The result: more value than any imaginable acquisition.

So far, so obvious, you may be thinking. But counter-intuitively, it is not always necessary to be the first-to-market with a new innovation to reap significant commercial rewards. The most critical element is to get to market quickly. Research from the Product Development Institute shows it is the first few entrants who capture high margins, with the late-comers forced to achieve only commodity returns as they compete with multiple providers.

Furthermore, it is critical to meet demand with high quality right from the outset. Second chances to relaunch services or products due to poor quality are fast becoming unaffordable luxuries. And finally, it is critical to be able to rapidly scale to meet rising success and keep followers at bay (1).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
Carl Dugdale is the Senior Vice President and European Managing Director of George Group Consulting. Carl heads George Group’s European operations, advising senior and board-level corporate leaders on major business transformation programmes. Originally trained as a Physicist, with a BSc Hons, Carl gained an MBA from London Business School and keeps up-to-date with short courses at Harvard and Insead.
spacer
Carl Dugdale
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

• Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up • Tailored upstream development from a single source reduces time to clinic by 20 percent • Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

Sterile Vials Made of Tubular Glass

Gerresheimer AG

Gx® RTF vials powered by Ompi EZ-fill® enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and ready-to-fill processing for our pharma and biotech customers.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement